Anti-tumor activity and apoptosis-regulation mechanisms of bufalin in various cancers: New hope for cancer patients

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 11, 2012, Pages 5339-5343

  Yin, Pei Hao ^a   Liu, Xuan ^a   Qiu, Yan Yan ^a   Cai, Jian feng ^b   Qin, Jian min ^a   Zhu, Hui Rong ^a   Li, Qi ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Anti apoptotic proteins; Bcl 2; Bufalin; Caspase 3; Chemotherapy; PI3K Akt pathway

Indexed keywords

EID: 84874101675     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.11.5339     Document Type: Review

References (47)

1. Chen A, Yu J, Zhang L, Sun Y, et al (2009). Microarray and Biochemical analysis of Bufalin-induced apoptosis of HL-60 cells. Biotechnol Lett, 31, 487-94.
2. Chen XY, Hu WL, Xu RC, et al (2001). Effect of Bufalin on cytotoxicity and growth related gene expression of human hepatoma cell line SMMC7721. Chin J Pharmacol Toxicol, 15, 293-96 (in Chinese).
3. Chen XY, Xu RC, Chen L, et al (2000). Apoptosis of gastric cancer cells induced by Bufalin. Basic Clin Med, 20, 50-3 (in Chinese).
4. Colon J, Basha MR, Madero-Visbal R, et al (2011). Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice. Invest New Drugs, 29, 41-51.
5. Cory S, Adams JM (2002). The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer, 2, 647-56.
6. Dong Y, Yin S, Li J, et al (2011). Bufadienolide compounds sensitize human breast cancer cells to TRAIL-induced apoptosis via inhibition of STAT3/Mcl-1 pathway. Apoptosis, 16, 394-403.
7. Ferlay J, Shin HR, Bray F, et al (2010). GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 (internet). Lyon, France: International Agency for Research on Cancer.
8. Gluecksmann A (1951). Cell death in normal vertebrate ontogeny. Biol Rev, 26, 59-86.
9. Han K, Huang G, Gu W, et al (2007). Anti-tumor activities and apoptosis-regulated mechanisms of Bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice. World J Gastroenterol, 13, 3374-9.
10. Hashimoto S, Jing Y, Kawazoe N, et al (1997). Bufalin reduces level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs. Leukemia Res, 21, 875-83.
11. Hong Z, Chan K, Yeung HW, et al (1992). Simultaneous determination of bufadienolides in the traditional Chinese medicine preparation, Liu-Shen-Wan, by liquid chromatography. J Pharm Pharmacol, 44, 1023-6.
12. Jiang Y, Zhang Y, Luan J, et al (2010). Effects of Bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action. Cytotechnology, 62, 573-83.
13. Kasof GM, Gomes BC (2001). Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem, 276, 3238- 46.
14. Kaufmann SH, Earnshaw WC (2000). Induction of apoptosis by cancer chemotherapy. Exp Cell Res, 256, 42-9.
15. Kawazoe N, Watabe M, Masuda Y, et al (1999). Tiam1 is involved in the regulation of Bufalin-induced apoptosis in human leukemia cells. Oncogene, 18, 2413-21.
16. Kerr JFR, Winterford CM, Harmon CV, et al (1994). Apoptosis - its significance in cancer and cancer therapy. Cancer, 73, 2013-26.
17. Kim S, Lee UJ, Kim MN, et al (2008). MicroRNA miR-199a regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2). J Biol Chem, 283, 18158-66.
18. Krueger A, Baumann S, Krammer PH, et al (2001). FLICEinhibitory proteins: regulators of death receptor-mediated apoptosis. Mol Cell Biol, 21, 8247-54.
19. Li D, Qu X, Hou K, et al (2009). PI3K/Akt is involved in Bufalin-induced apoptosis in gastric cancer cells. Anticancer Drugs, 20, 59-64.
20. Liu C, Wu X, Luo C, et al (2010). Antisense oligonucleotide targeting Livin induces apoptosis of human bladder cancer cell via a mechanism involving caspase 3. J Exp Clin Cancer Res, 29, 63.
21. Lockshin RA, Zakeri Z (2001). Programmed cell death and apoptosis: origins of the theory. Nat Rev Mol Cell Biol, 2, 545-50.
22. Masuda Y, Kawazoe N, Nakajo S, et al (1995). Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leukemia Res, 19, 549-56.
23. Meng Z, Yang P, Shen Y, et al (2009). Pilot study of huachansu in patients with hepatocellular carcinoma, non small-cell lung cancer, or pancreatic cancer. Cancer, 115, 5309-18.
24. Morelli MP, Cascone T, Troiani T, et al (2006). Anti-tumor activity of the combination of cetuximab, an anti-EGFR blocking monoclonal antibody and ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinases. Cell Physiol, 208, 344-53.
25. Naumov GN, Nilsson MB, Cascone T, et al (2009). Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance. Clin Cancer Res, 15, 3484-94.
26. Panesar NS (1994). Bufalin radio immunoassays: in search of the endogenous digitalis- like substance. J Immunoassay, 15, 371-91.
27. Puri N, Salgia R (2008). Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer. J Carcinog, 7, 9.
28. Qi F, Inagaki Y, Gao B, et al (2011). Bufalin and cinobufagin induce apoptosis of human hepatocellular carcinoma cells via Fas and mitochondria-mediated pathways. Cancer Sci, 102, 951-58.
29. Sanna MG, da Silva CJ, Ducrey O, et al (2002). IAP suppression of apoptosis involves distinct mechanisms: The TAK1/ JNK1signaling cascade and caspase inhibition. Mol Cell Biol, 22, 1754-66.
30. Takai N, Ueda T, Nishida M, et al (2008). Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells. Int J Mol Med, 21, 637-43.
31. Thome M, Tschopp J, et al (2001). Regulation of lymphocyte proliferation and death by FLIP. Nat Rev Immunol, 1, 50-8.
32. Tian X, Lou Y, Liu YP, et al (2006). Down regulation of Bcl-2 and survivin expression and release of Smac/DIABLO involved in Bufalin induced HL-60 cell apoptosis. Chin J Hematol, 27, 21-4 (in Chinese).
33. Wang S, Liu Q, Zhang Y, et al (2009). Suppression of growth, migration and invasion of highly metastatic human breast cancer cells by berbamine and its molecular mechanisms of action. Mol Cancer, 8, 81.
34. Watabe M, Kawazoe N, Masuda Y, et al (1997). Bcl-2 protein inhibits Bufalin induced apoptosis through inhibition of mitogen activated protein kinase activation in human leukemia U937 cells. Cancer Res, 57, 3097-00.
35. Watabe M, Masuda Y, Nakajo S, et al (1996). The cooperative interaction of two different signaling pathways in response to Bufalin induces apoptosis in human leukemia U937 cells. J Biol Chem, 271, 14067-72.
36. Willis S, Day CL, Hinds MG, et al (2003). The Bcl-2-regulated apoptotic pathway. J Cell Sci, 116, 4053-6.
37. Wu XX, Lu Q, Zhang M, et al (2000). Apoptosis of gastric cancer cells induced by Bufalin. Jichu Yanjiu yu Linchuang, 20, 50-2 (in Chinese)
38. Wyllie AH, Kerr JF, Currie AR (1980). Cell death: the significance of apoptosis. Int Rev Cytol, 68, 251-306.
39. Yamada K, Hino K, Tomoyasu S, et al (1998). Enhancement by Bufalin of retinoic acid-induced differentiation of acute promyelocytic leukemia cells in primary culture. Leukemia Res, 22, 589-95.
40. Yeh JY, Huang WJ, Kan SF, et al (2003). Effects of Bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells. Prostate, 54, 112-24.
41. Yin P, Wang Y, Qiu Y, et al (2012). Bufalin-loaded mPEGPLGA- PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity. Int J Nanomedicine, 7, 3961-69.
42. Yu CH, Kan SF, Pu HF, et al (2008). Apoptotic signaling in Bufalin and cinobufagin treated androgen-dependent and independent human prostate cancer cells. Cancer Sci, 99, 2467-76.
43. Yu P, Liu Q, Liu K, et al (2009). Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF-kappaB signaling. Cytotechnology, 59, 219-29.
44. Zhang L, Nakaya K, Yoshida T, et al (1992). Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers. Cancer Res, 52, 4634-41.
45. Zhang LS, Nakaya K, Yoshida T, et al (1991). Bufalin as a potent inducer of differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun, 178, 686-93.
46. Zhu ZT, Jin B, Liu YP, et al (2006). [Enhancement of all-trans retinoic acid-induced differentiation by bufalin in primary culture of acute promyelocytic leukemia cells]. Chin J Int Med, 45, 314-7. (in Chinese)
47. Zhu Z, Sun H, Ma G, et al (2012). Bufalin induces lung cancer cell apoptosis via the inhibition of PI3K/Akt pathway. Int J Mol Sci, 13, 2025-35.